Precision Coating Merging with N2 Biomedical to Expand Medical Coatings Platform

Precision Coating, a medical coatings service provider to orthopedic and other markets, announced a merger with N2 Biomedical, provider of nano-engineered surface treatment and coating services to the medical device industry with its low-temperature Ion Implantation Surface Treatments and Ion Beam Assisted Deposition technologies.

“We are very excited to add N2’s technologies and people to Precision Coating. N2 extends our coating platform technologies in ways that enhance our value proposition for customers. This is particularly true in orthopedics, where we can now offer engineered coating solutions across both instruments and implants,” said Bill Ellerkamp, President of Precision Coating. “The two companies have a great deal of complementarity between market focus, customer overlap, product functional properties, and operational execution, not to mention geographic proximity.”

Also, we are pleased to welcome Keith Edwards, CEO of N2, and Heidi DeGrazia, CFO of N2, to the Precision Coating executive leadership team. “The Precision Coating/N2 Biomedical merger pairs two firms with long histories of technology innovation, exceptional quality, continuous improvement, and a focus on supply performance,” commented Keith Edwards. “Together we will excel as a trusted partner to the medical device community.”

Precision Coating’s MICRALOX® portfolio is a standard for aluminum anodizing finishes for barrier properties, corrosion resistance and extended product life cycles, targeting orthopedic and advanced surgical instruments.

N2 provides coating and surface treatment development and application services for implantable and other medical devices used in orthopedic and other healthcare end-markets.

Source: N2 Biomedical

JAV

Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE